AEArthur Guastala Engler

Arthur Guastala Engler

*This is an algorithmically generated author record based on publicly available information.

Arthur Guastala Engler has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    USE OF CURCUMA LONGA L. AS A DRUG: A BIBLIOGRAPHIC ESSAY ABOUT THE MECHANISMS OF THE ACTION OF THE CONSTITUENTS OF THE SPECIES AGAINST PATHOLOGICAL PROCESSES.

    by Jefferson Alessandro Schmitz Junior, Arthur Guastala Engler, Valéria Luz Cunha Pint, Kassiely Zamarch, Filipe Andrich, Hélida Mara Magalhães, Meire Pereira de Souza Ferrari

    In the present work, the objective was to list the activities and mechanisms of action that classify as promising agents in the treatment of pathogenic processes the human species the constituents of the species Curcuma longa L. (or as it is popularly known, turmeric). Taking into account the phytotherapic characteristics of the species, it is suggested to use it as an alternative in the treatment of inflammatory processes caused by biological agents, or even in the treatment of diseases such as cancer and Alzheimer's. The studies addressed show antibacterial, antifungal, antitumor properties, and among others, as being attributed to the species mainly thanks to its main and major phenolic constituent: curcumin. The work was developed from studies in the scientific literature, through research platforms such as academic google and scielo, in addition to the use of books. Thanks to the results obtained, it is possible to classify the plant, which was already commonly used in some pathological processes, as a way to treat diseases and even as cosmetics. It is then suggested the study and development of drugs that address the use of curcumin in its composition, since the biological and chemical activities of this compound are proven to help in the treatment of some pathological processes.